These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5788524)

  • 21. A comparison of the effects of neuromuscular blocking agents and cholinesterase inhibitors on the tibialis anterior and superior rectus muscles of the cat.
    Katz RL; Eakins KE
    J Pharmacol Exp Ther; 1966 May; 152(2):304-12. PubMed ID: 5944372
    [No Abstract]   [Full Text] [Related]  

  • 22. Relationships between in vivo and in vitro inhibition of acetylcholinesterase (AChE) and impairment of neuromuscular transmission in the rat phrenic-nerve diaphragm by a tertiary anticholinesterase and its quaternary analogue.
    Lancaster R
    Biochem Pharmacol; 1973 Aug; 22(15):1875-81. PubMed ID: 4352918
    [No Abstract]   [Full Text] [Related]  

  • 23. Action of some bisquaternary derivatives of phthalic acids and related substances on neuromuscular transmission.
    Danilov AF; Kvitko IJ; Lavrentieva VV; Michelson MJ; Porai-Koshits BA; Rozhkova EK; Shelkovnikov SA
    Br J Pharmacol; 1972 Apr; 44(4):765-78. PubMed ID: 4339387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Neuromuscular blocking effect of ORG9426, a new non-depolarizing muscle relaxant, and its recovery with various antagonists in vitro].
    Okamoto T; Aoki T; Fukushima K; Yoneda I; Satoh T; Nagashima H
    Masui; 1992 Sep; 41(9):1467-73. PubMed ID: 1433879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Blocking of the neuromuscular conduction by decamethylene-bis-pyridinium].
    Danilov AF
    Farmakol Toksikol; 1970; 33(5):536-8. PubMed ID: 4250151
    [No Abstract]   [Full Text] [Related]  

  • 26. Reversal of a soman-induced effect on neuromuscular function without reactivation of cholinesterase.
    Loomis TA; Johnson DD
    Toxicol Appl Pharmacol; 1966 May; 8(3):528-32. PubMed ID: 5961568
    [No Abstract]   [Full Text] [Related]  

  • 27. The responses of acetylcholinesterase and conduction in bull-frog sciatic nerve to the stereochemistry of amino alcohol derivatives. III.
    FRIESS SL; WHITCOMB ER; DURANT RC; REBER LJ
    Arch Biochem Biophys; 1959 Dec; 85():426-36. PubMed ID: 13825217
    [No Abstract]   [Full Text] [Related]  

  • 28. On the role of the ester groups in the internitrogen chain in the action of bisquaternary compounds on skeletal muscles.
    Danilov AF; Guli-Kevkhyan RS; Lavrentieva VV; Michelson MJ; Mndjoyan OL; Shelkovnikov SA; Starshinova LA
    Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):35-51. PubMed ID: 4844369
    [No Abstract]   [Full Text] [Related]  

  • 29. [CHEMICAL AND PHARMACOLOGICAL STUDY OF THE PHOSPHORIC ESTERS OF P-NITROPHENOL AND P-NITROBENZYL ALCOHOL].
    CHEYMOL J; CHABRIER P; THUONG NT; CHOISY H
    Therapie; 1964; 19():929-39. PubMed ID: 14190949
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of colchicine and vinblastine on neurotubules of the sciatic nerve and cholinesterases in the developing myoneural junction of the rat.
    Juntunen J
    Z Zellforsch Mikrosk Anat; 1973; 142(2):193-204. PubMed ID: 4355694
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of adrenergic neurone blocking agents on voluntary muscle stimulated at different frequencies.
    Green AF; Hughes R
    Br J Pharmacol Chemother; 1966 May; 27(1):164-76. PubMed ID: 5961463
    [No Abstract]   [Full Text] [Related]  

  • 32. Modification of adrenaline action at the neuromuscular junctiin by bivalent metals and adrenergic receptor blocking agents.
    Paranjpe BD; Rajapurkar MV
    Indian J Med Res; 1969 Oct; 57(10):1921-31. PubMed ID: 4391954
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects on cardiac muscle of the -adrenoceptor blocking drugs INPEA and LB46 in relation to their local anaesthetic action on nerve.
    Singh BN; Williams EM
    Br J Pharmacol; 1971 Sep; 43(1):10-22. PubMed ID: 4400181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of new guanidine derivatives on ganglionic and neuromuscular transmission.
    Kadzielawa K; Gumulka W
    Arch Int Pharmacodyn Ther; 1967 Dec; 170(2):297-309. PubMed ID: 4294771
    [No Abstract]   [Full Text] [Related]  

  • 35. Screening of some basic amides for local anaesthetic and neuromuscular blocking activity.
    Derasari HR; Patel MN
    Indian J Physiol Pharmacol; 1973; 17(1):55-62. PubMed ID: 4270899
    [No Abstract]   [Full Text] [Related]  

  • 36. Neuromuscular function in the absence of cholinesterase.
    Loomis TA
    Arch Int Pharmacodyn Ther; 1967 Feb; 165(2):319-27. PubMed ID: 6031466
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effects of so-called "depolarizing" and "repolarizing" substances on neuromuscular excitability].
    Quevauviller A; Levy JC
    Anesth Analg (Paris); 1967; 24(2):247-68. PubMed ID: 4383825
    [No Abstract]   [Full Text] [Related]  

  • 38. Neuromuscular blocking activity and other pharmacologic properties of various carnitine derivatives.
    Hosein EA; Booth SJ; Gasoi I; Kato G
    J Pharmacol Exp Ther; 1967 Jun; 156(3):565-72. PubMed ID: 6028881
    [No Abstract]   [Full Text] [Related]  

  • 39. Beta-Adrenergic blocking agents. V. 1-Amino-3-(substituted phenoxy)-2-propanols.
    Crowther AF; Gilman DJ; McLoughlin BJ; Smith LH; Turner RW; Wood TM
    J Med Chem; 1969 Jul; 12(4):638-42. PubMed ID: 5793156
    [No Abstract]   [Full Text] [Related]  

  • 40. Neostigmine: how much is necessary for patients who receive a nondepolarizing neuromuscular blocking agent?
    Lien CA
    Anesthesiology; 2010 Jan; 112(1):16-8. PubMed ID: 19952723
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.